Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Möbs

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 5, 2011
Pathogenesis of Mycosis fungoidesMarc Beyer, Markus Möbs, Daniel Humme, et al.
Archives of Dermatological Research|December 10, 2014
Analysis of the IL-31 pathway in Mycosis fungoides and Sézary syndromeMarkus Möbs, Stefanie Gryzik, Ahmed Haidar, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 3, 2015
Evaluation of blood parameters for the monitoring of erythrodermic cutaneous T-cell lymphomaStaffan Vandersee, Daniel Humme, Dorothea Terhorst, et al.
Skin Pharmacology and Physiology|March 23, 2016
The Effects of Arsenic Trioxide in Combination with Retinoic Acids on Cutaneous T-Cell Lymphoma Cell LinesMarc Beyer, Staffan Vandersee, Ioana Cosagarea, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 1, 2013
Molecular diagnostics in cutaneous lymphomasMarkus Möbs, Lorenzo Cerroni, Michael J Flaig, et al.
Expert Opinion on Biological Therapy|November 8, 2008
Zanolimumab, a human monoclonal antibody targeting CD4 in the treatment of mycosis fungoides and Sézary syndromeDominik Sebastian Mestel, Marc Beyer, Markus Möbs, et al.
The Journal of Investigative Dermatology|October 21, 2011
Nonsteroidal anti-inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligandFrank K Braun, Nadya Al-Yacoub, Michael Plötz, et al.
Oncoimmunology|March 28, 2017
IL-32 induces indoleamine 2,3-dioxygenase<sup>+</sup>CD1c<sup>+</sup> dendritic cells and indoleamine 2,3-dioxygenase<sup>+</sup>CD163<sup>+</sup> macrophages: Relevance to mycosis fungoides progressionHanako Ohmatsu, Daniel Humme, Juana Gonzalez, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 27, 2010
Evaluation of T-cell clonality in archival skin biopsy samples of cutaneous T-cell lymphomas using the biomed-2 PCR protocolAnsgar Lukowsky, J Marcus Muche, Markus Möbs, et al.
The Journal of Investigative Dermatology|May 4, 2012
Apoptosis induction by SAHA in cutaneous T-cell lymphoma cells is related to downregulation of c-FLIP and enhanced TRAIL signalingNadya Al-Yacoub, Lothar F Fecker, Markus Möbs, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 5, 2011
Pathogenesis of Mycosis fungoidesMarc Beyer, Markus Möbs, Daniel Humme, et al.
Archives of Dermatological Research|December 10, 2014
Analysis of the IL-31 pathway in Mycosis fungoides and Sézary syndromeMarkus Möbs, Stefanie Gryzik, Ahmed Haidar, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 3, 2015
Evaluation of blood parameters for the monitoring of erythrodermic cutaneous T-cell lymphomaStaffan Vandersee, Daniel Humme, Dorothea Terhorst, et al.
Skin Pharmacology and Physiology|March 23, 2016
The Effects of Arsenic Trioxide in Combination with Retinoic Acids on Cutaneous T-Cell Lymphoma Cell LinesMarc Beyer, Staffan Vandersee, Ioana Cosagarea, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 1, 2013
Molecular diagnostics in cutaneous lymphomasMarkus Möbs, Lorenzo Cerroni, Michael J Flaig, et al.
Expert Opinion on Biological Therapy|November 8, 2008
Zanolimumab, a human monoclonal antibody targeting CD4 in the treatment of mycosis fungoides and Sézary syndromeDominik Sebastian Mestel, Marc Beyer, Markus Möbs, et al.
The Journal of Investigative Dermatology|October 21, 2011
Nonsteroidal anti-inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligandFrank K Braun, Nadya Al-Yacoub, Michael Plötz, et al.
Oncoimmunology|March 28, 2017
IL-32 induces indoleamine 2,3-dioxygenase<sup>+</sup>CD1c<sup>+</sup> dendritic cells and indoleamine 2,3-dioxygenase<sup>+</sup>CD163<sup>+</sup> macrophages: Relevance to mycosis fungoides progressionHanako Ohmatsu, Daniel Humme, Juana Gonzalez, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 27, 2010
Evaluation of T-cell clonality in archival skin biopsy samples of cutaneous T-cell lymphomas using the biomed-2 PCR protocolAnsgar Lukowsky, J Marcus Muche, Markus Möbs, et al.
The Journal of Investigative Dermatology|May 4, 2012
Apoptosis induction by SAHA in cutaneous T-cell lymphoma cells is related to downregulation of c-FLIP and enhanced TRAIL signalingNadya Al-Yacoub, Lothar F Fecker, Markus Möbs, et al.
Pageof 5